Send us a text

In this episode, Ana Reisdorf speaks with Josh Sanders, the director of pharmacy at OnSiteRx, about the complexities of pharmacy benefits managers (PBMs) and their impact on drug pricing, particularly for GLP-1 medications like Ozempic, Mounjaro, or Zpebound. 

They discuss the role of PBMs in formulary management, the use of copay cards, the implications of compounding pharmacies, and the challenges posed by prior authorizations. The conversation also touches on the future of GLP-1 medications, concerns over their widespread use, and the importance of advocating for oneself in the healthcare system.

About Josh:

Josh Sanders, PharmD is a seasoned professional with over a decade of experience in optimizing pharmacy operations and delivering significant cost savings within complex healthcare environments. As the Director of Pharmacy at On-Site Rx, he leads strategic oversight for ten pharmacies across four states and advises large self-funded employers on benefits design. His expertise spans clinical guidance, operational efficiency, and navigating the evolving landscape of pharmaceutical care.

About our sponsors:

Visit Calocurb.com and use the code ANA10 for 10% off

Visit Gruns.co and use the code GLP1HUB for 52% off

Visit Hero.co and use the code GLP1HUB for 10% off

Visit our GLP-1 Hub store:

https://www.glp-1hub.com

Get our FREE 7-day meal plans for GLP-1:

7-Day Meal Plan

Plant-based 7-Day Meal Plan

Want to connect more with GLP-1 Hub?

Instagram: https://www.instagram.com/glp1hub

Tiktok: https://www.tiktok.com/@glp1hub

YouTube: https://www.youtube.com/@glp-1hub

Weekly newsletter with weight loss tips and podcast updates: https://glp1hub.myflodesk.com/rn9j3lxjpp

*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.

*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.